Literature DB >> 26272259

Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells.

Anoop Kumar1, Waddah A Alrefai2, Alip Borthakur3, Pradeep K Dudeja2.   

Abstract

Butyrate, a key short-chain fatty acid metabolite of colonic luminal bacterial action on dietary fiber, serves as a primary fuel for the colonocytes, ameliorates mucosal inflammation, and stimulates NaCl absorption. Absorption of butyrate into the colonocytes is essential for these intracellular effects. Monocarboxylate transporter 1 (MCT1) plays a major role in colonic luminal butyrate absorption. Previous studies (Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. Adv Immunol 121: 91-119, 2014.) showed decreased MCT1 expression and function in intestinal inflammation. We have previously shown (Borthakur A, Gill RK, Hodges K, Ramaswamy K, Hecht G, Dudeja PK. Am J Physiol Gastrointest Liver Physiol 290: G30-G35, 2006.) impaired butyrate absorption in human intestinal epithelial Caco-2 cells due to decreased MCT1 level at the apical cell surface following enteropathogenic E. coli (EPEC) infection. Current studies, therefore, examined the potential role of probiotic Lactobacilli in stimulating MCT1-mediated butyrate uptake and counteracting EPEC inhibition of MCT1 function. Of the five species of Lactobacilli, short-term (3 h) treatment with L. acidophilus (LA) significantly increased MCT1-mediated butyrate uptake in Caco-2 cells. Heat-killed LA was ineffective, whereas the conditioned culture supernatant of LA (LA-CS) was equally effective in stimulating MCT1 function, indicating that the effects are mediated by LA-secreted soluble factor(s). Furthermore, LA-CS increased apical membrane levels of MCT1 protein via decreasing its basal endocytosis, suggesting that LA-CS stimulation of butyrate uptake could be secondary to increased levels of MCT1 on the apical cell surface. LA-CS also attenuated EPEC inhibition of butyrate uptake and EPEC-mediated endocytosis of MCT1. Our studies highlight distinct role of specific LA-secreted molecules in modulating colonic butyrate absorption.

Entities:  

Keywords:  Caco-2; SCFA; endocytosis; pCMBS; probiotics

Mesh:

Substances:

Year:  2015        PMID: 26272259      PMCID: PMC4593819          DOI: 10.1152/ajpgi.00186.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  44 in total

1.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 2.  Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.

Authors:  M A Gassull
Journal:  Aliment Pharmacol Ther       Date:  2006-10       Impact factor: 8.171

Review 3.  Probiotics, gut microbiota and health.

Authors:  M-J Butel
Journal:  Med Mal Infect       Date:  2013-11-28       Impact factor: 2.152

4.  Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells.

Authors:  Anoop Kumar; Cameron Hecht; Shubha Priyamvada; Arivarasu N Anbazhagan; Anas Alakkam; Alip Borthakur; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-20       Impact factor: 4.249

Review 5.  Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.

Authors:  Ronan Thibault; François Blachier; Béatrice Darcy-Vrillon; Pierre de Coppet; Arnaud Bourreille; Jean-Pierre Segain
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

6.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

7.  Lactobacillus acidophilus attenuates downregulation of DRA function and expression in inflammatory models.

Authors:  Varsha Singh; Anoop Kumar; Geetu Raheja; Arivarasu N Anbazhagan; Shubha Priyamvada; Seema Saksena; Muhammad Nauman Jhandier; Ravinder K Gill; Waddah A Alrefai; Alip Borthakur; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

8.  Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation.

Authors:  Ronan Thibault; Pierre De Coppet; Kristian Daly; Arnaud Bourreille; Mark Cuff; Christian Bonnet; Jean-François Mosnier; Jean-Paul Galmiche; Soraya Shirazi-Beechey; Jean-Pierre Segain
Journal:  Gastroenterology       Date:  2007-08-22       Impact factor: 22.682

Review 9.  Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation.

Authors:  Mayu Kasubuchi; Sae Hasegawa; Takero Hiramatsu; Atsuhiko Ichimura; Ikuo Kimura
Journal:  Nutrients       Date:  2015-04-14       Impact factor: 5.717

Review 10.  Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation.

Authors:  Chang H Kim; Jeongho Park; Myunghoo Kim
Journal:  Immune Netw       Date:  2014-12-22       Impact factor: 6.303

View more
  28 in total

1.  Gut microbiota: Lactobacillus acidophilus opens the door to butyrate.

Authors:  Gillian Patman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.

Authors:  Hayley Coffing; Shubha Priyamvada; Arivarasu N Anbazhagan; Christine Salibay; Melinda Engevik; James Versalovic; Mary Beth Yacyshyn; Bruce Yacyshyn; Sangeeta Tyagi; Seema Saksena; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

Review 3.  Butyrate: A Double-Edged Sword for Health?

Authors:  Hu Liu; Ji Wang; Ting He; Sage Becker; Guolong Zhang; Defa Li; Xi Ma
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

4.  Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.

Authors:  Da Zhou; Qin Pan; Feng-Zhi Xin; Rui-Nan Zhang; Chong-Xin He; Guang-Yu Chen; Chang Liu; Yuan-Wen Chen; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 5.  Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.

Authors:  Sathish Sivaprakasam; Yangzom D Bhutia; Shengping Yang; Vadivel Ganapathy
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 6.  Impact of probiotics on necrotizing enterocolitis.

Authors:  Mark A Underwood
Journal:  Semin Perinatol       Date:  2016-11-08       Impact factor: 3.300

7.  Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.

Authors:  Raymond Evers; Micheline Piquette-Miller; Joseph W Polli; Frans G M Russel; Jason A Sprowl; Kimio Tohyama; Joseph A Ware; Saskia N de Wildt; Wen Xie; Kim L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2018-07-12       Impact factor: 6.875

Review 8.  Insights into human evolution from ancient and contemporary microbiome studies.

Authors:  Stephanie L Schnorr; Krithivasan Sankaranarayanan; Cecil M Lewis; Christina Warinner
Journal:  Curr Opin Genet Dev       Date:  2016-08-06       Impact factor: 5.578

9.  Function and Phylogeny of Bacterial Butyryl Coenzyme A:Acetate Transferases and Their Diversity in the Proximal Colon of Swine.

Authors:  Julian Trachsel; Darrell O Bayles; Torey Looft; Uri Y Levine; Heather K Allen
Journal:  Appl Environ Microbiol       Date:  2016-10-27       Impact factor: 4.792

Review 10.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.